Clinical Trial Search Results

Study to determine if the addition of radium-223 dichloride to standard treatment is able to prolong life and to delay events specific for prostate cancer.

Study evaluates the safety and efficacy of atezolizumab in combination with enzalutamide compared with enzalutamide alone in participants with mCRPC.

Study of ADXS31-142 monotherapy and a combination of ADXS31-142 with Pembrolizumab (MK-3475) in patients with metastatic castration-resistant prostate cancer.

Study to demonstrate the superiority in term of radiographic Progression-Free Survival (rPFS) of cabazitaxel in patients with metastatic Castration-Resistant Prostate Cancer.

Study to evaluate the short and long term safety profile of Radium-223 in metastatic castration resistant prostate cancer patients.

The purpose of this study is to evaluate the efficacy and safety of ARN-509 in adult men with high-risk non-metastatic castration-resistant prostate cancer.

Study to determine if the addition of apalutamide to ADT provides superior efficacy in improving radiographic progression-free survival (rPFS).

Study to determine whether DCVAC/PCa added onto Standard of Care Chemotherapy can improve survival times for patients with Metastatic Castration Resistant Prostate Cancer.